Shusuke Yagi Selected Research

Scarlet Red (Sudan IV)

11/2023	Olive mill wastewater and hydroxytyrosol inhibits atherogenesis in apolipoprotein E-deficient mice.
6/2021	Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient Mice.
11/2019	Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shusuke Yagi Research Topics

Disease

21	Atherosclerosis 11/2023 - 06/2007
19	Inflammation (Inflammations) 01/2023 - 02/2010
14	Hypertension (High Blood Pressure) 07/2023 - 01/2008
13	Neoplasms (Cancer) 04/2024 - 01/2011
11	Heart Failure 01/2024 - 10/2009
9	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2019
9	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 10/2009
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2012
8	Atherosclerotic Plaque (Atheroma) 11/2019 - 09/2011
7	Insulin Resistance 09/2022 - 02/2010
7	Fibrosis (Cirrhosis) 01/2021 - 08/2005
6	Body Weight (Weight, Body) 11/2023 - 02/2010
6	Type 2 Diabetes Mellitus (MODY) 01/2023 - 08/2015
6	Acute Coronary Syndrome 03/2019 - 01/2008
5	Hemorrhage 06/2023 - 01/2019
5	Atrial Fibrillation 03/2023 - 04/2010
5	Ischemia 01/2018 - 01/2013
4	Thrombosis (Thrombus) 03/2023 - 12/2011
4	Venous Thromboembolism 07/2022 - 01/2018
4	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2011
4	Diabetes Mellitus 01/2021 - 01/2011
4	Rupture 01/2019 - 09/2011
4	Obesity 01/2016 - 01/2011
3	Venous Thrombosis (Deep-Vein Thrombosis) 07/2020 - 01/2019
3	Myocardial Infarction 01/2019 - 08/2006
3	Essential Hypertension 01/2015 - 01/2011
3	Vascular Remodeling 01/2011 - 06/2007
3	Hypertrophy 04/2010 - 08/2005
2	Bites and Stings (Sting) 11/2023 - 11/2021
2	Amyloidosis 04/2023 - 01/2007
2	Neoplasm Metastasis (Metastasis) 02/2022 - 02/2021
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022 - 01/2008
2	Cardiac Arrhythmias (Arrythmia) 01/2021 - 01/2017
2	Pulmonary Arterial Hypertension 01/2021 - 01/2010
2	Proteinuria 01/2020 - 11/2012
2	Thrombophilia 01/2019 - 12/2011

Drug/Important Bio-Agent (IBA)

14	LipidsIBA 11/2023 - 01/2013
11	ApolipoproteinsIBA 11/2023 - 04/2016
10	Apolipoproteins E (ApoE)IBA 11/2021 - 10/2015
7	Angiotensin IIIBA 01/2021 - 08/2005
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2019 - 01/2008
7	Docosahexaenoic AcidsIBA 03/2019 - 12/2014
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2011
6	Eicosapentaenoic AcidIBA 03/2019 - 12/2014
5	Blood Glucose (Blood Sugar)IBA 11/2023 - 04/2016
5	RivaroxabanIBA 07/2022 - 10/2015
5	AnticoagulantsIBA 07/2022 - 10/2015
5	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 10/2015
5	AndrogensIBA 01/2021 - 08/2005
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2023 - 04/2010
4	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2010
4	pitavastatin (itavastatin)FDA Link 01/2018 - 01/2008
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017 - 10/2009
4	Androgen Receptors (Androgen Receptor)IBA 07/2013 - 08/2005
3	InterferonsIBA 11/2023 - 05/2015
3	Scarlet Red (Sudan IV)IBA 11/2023 - 11/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2017
3	edoxabanIBA 07/2022 - 01/2018
3	Triglycerides (Triacylglycerol)IBA 12/2021 - 06/2011
3	ReninIBA 01/2020 - 01/2011
3	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2019 - 08/2015
3	Toll-Like Receptor 9IBA 01/2019 - 01/2016
3	CollagenIBA 10/2018 - 08/2005
3	SodiumIBA 01/2018 - 07/2016
3	Thrombin FDA Link 01/2018 - 06/2007
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2017 - 12/2014
3	CreatinineIBA 01/2017 - 06/2011
3	C-Reactive ProteinIBA 01/2017 - 09/2011
3	Arachidonic Acid (Vitamin F)IBA 12/2015 - 12/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2015 - 08/2006
3	LDL CholesterolIBA 01/2015 - 02/2010
3	MicroRNAs (MicroRNA)IBA 01/2015 - 01/2011
3	AldosteroneIBA 08/2014 - 01/2011
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2013 - 02/2010
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2023 - 11/2021
2	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2023 - 10/2017
2	Mitochondrial DNA (mtDNA)IBA 11/2023 - 11/2021
2	Streptozocin (Streptozotocin)FDA Link 11/2023 - 01/2016
2	Uric Acid (Urate)IBA 07/2023 - 01/2015
2	Prealbumin (Transthyretin)IBA 04/2023 - 01/2022
2	Amyloid (Amyloid Fibrils)IBA 04/2023 - 01/2022
2	Insulin (Novolin)FDA Link 01/2023 - 09/2022
2	apixabanIBA 07/2022 - 01/2019
2	HDL CholesterolIBA 12/2021 - 01/2015
2	Testosterone (Sustanon)FDA Link 01/2021 - 07/2010
2	CanagliflozinIBA 11/2020 - 01/2017
2	RNA (Ribonucleic Acid)IBA 05/2020 - 01/2019
2	cilnidipineIBA 01/2020 - 11/2012
2	Trastuzumab (Herceptin)FDA Link 01/2019 - 01/2019
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019 - 07/2016
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 01/2018

Therapy/Procedure

19	Therapeutics 12/2023 - 08/2006
5	Stents 03/2019 - 01/2008
4	Gastrectomy 01/2024 - 11/2019
4	Cardiac Rehabilitation 10/2018 - 01/2014
3	Neoadjuvant Therapy 06/2023 - 01/2022
3	Percutaneous Coronary Intervention 11/2021 - 12/2010
2	Adjuvant Chemotherapy 01/2024 - 03/2021
2	Drug Therapy (Chemotherapy) 03/2023 - 02/2021